<SEC-DOCUMENT>0001437749-25-020729.txt : 20250618
<SEC-HEADER>0001437749-25-020729.hdr.sgml : 20250618
<ACCEPTANCE-DATETIME>20250618073021
ACCESSION NUMBER:		0001437749-25-020729
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250618
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250618
DATE AS OF CHANGE:		20250618

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				474671997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		251055133

	BUSINESS ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mbrx20250617_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:mbrx="http://www.mbrx.com/20250618"><head>
	<title>mbrx20250617_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 6/17/2025 8:01:08 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="cursor: auto; padding: 0in 0.1in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20258K" name="dei:AmendmentFlag" id="ixv-257">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20258K" name="dei:EntityCentralIndexKey" id="ixv-258">0001659617</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="mbrx-20250618.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20258K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001659617</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-06-18</xbrli:startDate>
<xbrli:endDate>2025-06-18</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20258K" name="dei:DocumentType" id="ixv-268">8-K</ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric contextRef="d20258K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-269">June 18, 2025</ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div>&#160;</div>

<div style="text-align: center;"><img alt="logobig.jpg" src="logobig.jpg"/></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityRegistrantName" id="ixv-270">MOLECULIN BIOTECH, INC.</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-271">Delaware</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:EntityFileNumber" id="ixv-272">001-37758</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:EntityTaxIdentificationNumber" id="ixv-273">47-4671997</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction of</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation or Organization)</div>
			</td>
			<td style="vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File No.)</div>
			</td>
			<td style="vertical-align:top;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine1" id="ixv-274">5300 Memorial Drive, Suite 950</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressCityOrTown" id="ixv-275">Houston</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressStateOrProvince" id="ixv-276">TX</ix:nonNumeric> <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressPostalZipCode" id="ixv-277">77007</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices and zip code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20258K" name="dei:CityAreaCode" id="ixv-278">713</ix:nonNumeric>) <ix:nonNumeric contextRef="d20258K" name="dei:LocalPhoneNumber" id="ixv-279">300-5160</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed from last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-280">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-281">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-282">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-283">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Emerging growth company&#160;<ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-284">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.4%; border-top: 1px solid black; border-left: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.3%; border-top: 1px solid black; border-left: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol (s)</b></div>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 0.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.4%; border-left: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:Security12bTitle" id="ixv-285">Common Stock</ix:nonNumeric>, par value $.001 per share</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.3%; border-left: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:TradingSymbol" id="ixv-286">MBRX</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.4%; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20258K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-287">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 7.01 </b></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Regulation FD Disclosure</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">On June 18, 2025, Moleculin Biotech, Inc. (the &#8220;Company&#8221;), issued a press release which announced it has received a written response from the Office of Oncologic Diseases - Pediatric Oncology, of the U.S. Food and Drug Administration (FDA) regarding the Company&#8217;s Initial Pediatric Study Plan (iPSP), which was submitted after a June 2024 end-of-phase 1/2 meeting. The FDA has agreed to a single pediatric approval study in which Annamycin (also known as naxtarubicin) in combination with Cytarabine (also known as &#8220;Ara-C&#8221; and for which the combination of Annamycin and Ara-C is referred to as &#8220;AnnAraC&#8221;) will be evaluated as second line therapy in pediatric patients with relapsed/refractory acute myeloid leukemia (R/R AML), a form of cancer.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be &#8220;filed&#8221; for the purpose of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), unless specifically identified therein as being incorporated by reference.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Item 8.01</b></td>
			<td style="width: 90%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Other Events.</b></td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">On June 18, 2025, the Company announced it had received a written response from the Office of Oncologic Diseases - Pediatric Oncology, of the U.S. Food and Drug Administration (FDA) regarding the Company&#8217;s Initial Pediatric Study Plan (iPSP), which was submitted after a June 2024 end-of-phase 1/2 meeting. The FDA has agreed to a single pediatric approval study in which Annamycin (also known as naxtarubicin) in combination with Cytarabine (also known as &#8220;Ara-C&#8221; and for which the combination of Annamycin and Ara-C is referred to as &#8220;AnnAraC&#8221;) will be evaluated as second line therapy in pediatric patients with relapsed/refractory acute myeloid leukemia (R/R AML), a form of cancer.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">As&#160;part of the iPSP, the Company proposed a single-arm study evaluating pharmacokinetics (PK), efficacy, and safety of AnnAraC in patients between 2 and 16 years of age. The FDA response calls for including patients from 6 months of age and older, with no minimum number of patients between 6 months and 2 years old. FDA also clarified that drug concentration exposure and safety profile that are comparable would allow extrapolation from efficacy in adults. The FDA said Moleculin would be able to start the pediatric trial before having the full two years of follow-up data from the adult trial.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The Company is in the process of updating its iPSP to incorporate FDA&#8217;s recommendations and intends to submit the revised plan to FDA later this quarter. The Company expects to initiate pediatric clinical study in the second half of 2027.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01 </b></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(d)</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Exhibits.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>No.</b></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_831954.htm" style="-sec-extract:exhibit;">Press Release dated June 18, 2025</a></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover page Interactive Data File (formatted as Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><span style="text-decoration: underline;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:63pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:1.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MOLECULIN BIOTECH, INC.</b>&#160;</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td style="vertical-align:top;width:1.9%;">&#160;</td>
			<td style="vertical-align:top;width:15.7%;">&#160;</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td style="vertical-align:top;width:1.9%;">&#160;</td>
			<td style="vertical-align:bottom;width:15.7%;">&#160;</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td style="vertical-align:top;width:1.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:</div>
			</td>
			<td style="vertical-align:bottom;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;June 18, 2025</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td style="vertical-align:top;width:1.9%;">&#160;</td>
			<td style="vertical-align:bottom;width:15.7%;">&#160;</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td style="vertical-align:top;width:1.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/&#160;Jonathan P. Foster</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#160;</td>
			<td style="vertical-align:top;width:1.9%;">&#160;</td>
			<td style="vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jonathan P. Foster</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_831954.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_831954.htm</title>
	<!-- Generated by ThunderDome Portal - 6/17/2025 8:07:44 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family: Times New Roman; font-size: 12pt; font-variant: normal; margin: 0pt;"><img alt="logobig.jpg" src="logobig.jpg"></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>FDA recommends inclusion of patients as young as 6 months </i>&#8211;<i> younger than Moleculin had proposed </i>&#8211;<i> to be allowed in the pediatric clinical study</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>Enrollment and dosing are ongoing in pivotal, adaptive design Phase 3 MIRACLE trial of Annamycin in adult patients with R/R AML; Initial data readout is on track for the second half of 2025</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>HOUSTON,</b>&nbsp;<b>June 18, 2025</b>&nbsp;&#8212;&nbsp;<b>Moleculin Biotech, Inc.</b>, (Nasdaq: MBRX) (&#8220;Moleculin&#8221; or the &#8220;Company&#8221;), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced it has received a written response from the Office of Oncologic Diseases - Pediatric Oncology, of the U.S. Food and Drug Administration (FDA) regarding the Company&#8217;s Initial Pediatric Study Plan (iPSP), which was submitted after a June 2024 end-of-phase 1/2 meeting. The FDA has agreed to a single pediatric approval study in which Annamycin (also known as naxtarubicin) in combination with Cytarabine (also known as &#8220;Ara-C&#8221; and for which the combination of Annamycin and Ara-C is referred to as &#8220;AnnAraC&#8221;) will be evaluated as second line therapy in pediatric patients with relapsed/refractory acute myeloid leukemia (R/R AML), a form of cancer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;We continue to be encouraged by the potential of Annamycin to change the game when it comes to the most prevalent cancer therapies in use today. This is particularly important in pediatric oncology, where about 60% of children with cancer are treated with anthracyclines that present a high risk of causing heart damage. An independent expert&#8217;s review of study data has shown no cardiotoxicity to date in 84 adult patients treated with Annamycin, which is why we&#8217;re excited about moving forward in young children with cancer. Receiving this written feedback from FDA is a crucial step in the development of Annamycin for pediatric use and provides us with helpful insight as we continue to prepare for the launch of a pediatric trial, planned for the second half of 2027,&#8221; said Walter Klemp, Chairman and CEO of Moleculin. &#8220;As our team works to address and implement FDA&#8217;s feedback on our iPSP, we remain focused on the successful execution of our ongoing MIRACLE trial of AnnAraC in adult patients with R/R AML and look forward to initial data from that trial later this year.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As part of the iPSP, Moleculin proposed a single-arm study evaluating pharmacokinetics (PK), efficacy, and safety of AnnAraC in patients between 2 and 16 years of age. The FDA response calls for including patients from 6 months of age and older, with no minimum number of patients between 6 months and 2 years old. FDA also clarified that drug concentration exposure and safety profile that are comparable would allow extrapolation from efficacy in adults. Importantly, FDA said Moleculin would be able to start the pediatric trial before having the full two years of follow-up data from the adult trial.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin is in the process of updating its iPSP to incorporate FDA&#8217;s recommendations and intends to submit the revised plan to FDA later this quarter. Moleculin expects to initiate pediatric clinical study in the second half of 2027.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is currently evaluating AnnAraC for the treatment of adult patients with R/R AML in the pivotal, adaptive Phase 3 MIRACLE trial (MB-108). This &#8220;MIRACLE&#8221; trial (derived from <b><u>M</u></b>olecul<b><u>i</u></b>n <b><u>R</u></b>/R AML <b><u>A</u></b>nnAraC <b><u>Cl</u></b>inical <b><u>E</u></b>valuation) is a global trial, including sites in the US, Europe and the Middle East. Patient dosing has commenced, and the initial data readout is on track for the second half of 2025. For more information about the MIRACLE trial, visit <u>clinicaltrials.gov</u> and reference identifier NCT06788756</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">FDA has granted Annamycin Fast Track Status and Orphan Drug Designation for treating relapsed or refractory acute myeloid leukemia, and an additional Orphan Drug Designation for treating soft tissue sarcoma. The European Medicines Agency (EMA) has also granted Orphan Drug Designation for the treatment of relapsed or refractory acute myeloid leukemia.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About Moleculin Biotech, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company&#8217;s lead program, Annamycin, is a next-generation highly efficacious and well tolerated anthracycline designed to avoid multidrug resistance mechanisms and to eliminate the cardiotoxicity common with currently prescribed anthracyclines. The non-proprietary name for Annamycin is naxtarubicin. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases. Company discussions regarding Annamycin&#8217;s lack of cardiotoxicity reflect the following: 1) Annamycin was designed to be non-cardiotoxic; 2) Preclinical studies have demonstrated Annamycin lacks cardiotoxicity as compared to a currently prescribed anthracycline; and, 3) An independent expert&#8217;s conclusions after analyzing the data from 84 subjects treated with Annamycin in five clinical studies conducted in the US and in Europe.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has begun the MIRACLE (<b>M</b>olecul<b>i</b>n <b>R</b>/R AML <b>A</b>nnAraC <b>Cl</b>inical <b>E</b>valuation) Trial (MB-108), a pivotal, adaptive design Phase 3 trial evaluating Annamycin in combination with cytarabine for the treatment of relapsed or refractory acute myeloid leukemia. Following a successful Phase 1B/2 study (MB-106), with input from the FDA, the Company believes it has substantially de-risked the development pathway toward a potential approval for Annamycin for the treatment of AML. This study is subject to appropriate future filings with potential additional feedback from the FDA and foreign regulators.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin is also developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers. The Company also is developing a portfolio of antimetabolites, including WP1122 for the potential treatment of pathogenic viruses, as well as certain cancer indications.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For more information about the Company, please visit <u>www.moleculin.com</u> and connect on <u>X</u>, <u>LinkedIn</u> and <u>Facebook</u>.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the timing of the initiation of the pediatric clinical study. Moleculin will require significant additional financing, for which the Company has no commitments, in order to conduct its clinical trials as described in this press release, and the milestones described in this press release assume the Company&#8217;s ability to secure such financing on a timely basis. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Moleculin has attempted to identify forward-looking statements by terminology including &#8216;believes,&#8217; &#8216;estimates,&#8217; &#8216;anticipates,&#8217; &#8216;expects,&#8217; &#8216;plans,&#8217; &#8216;projects,&#8217; &#8216;intends,&#8217; &#8216;potential,&#8217; &#8216;may,&#8217; &#8216;could,&#8217; &#8216;might,&#8217; &#8216;will,&#8217; &#8216;should,&#8217; &#8216;approximately&#8217; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. &#8220;Risk Factors&#8221; in our most recently filed Form 10-K filed with the Securities and Exchange Commission (SEC) and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Investor Contact:</b><br>
JTC Team, LLC</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jenene Thomas</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(908) 824-0775</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>MBRX@jtcir.com</u></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mbrx-20250618.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/17/2025 8:05:37 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:mbrx="http://www.mbrx.com/20250618" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mbrx.com/20250618">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/cyd-8k-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20250618_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20250618_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20250618_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.mbrx.com/20250618/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mbrx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mbrx-20250618_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/17/2025 8:05:37 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.mbrx.com/20250618/role/statement-document-and-entity-information" xlink:href="mbrx-20250618.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.mbrx.com/20250618/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbrx-20250618_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/17/2025 8:05:37 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbrx-20250618_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/17/2025 8:05:38 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.mbrx.com/20250618/role/statement-document-and-entity-information" xlink:href="mbrx-20250618.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.mbrx.com/20250618/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logobig.jpg
<TEXT>
begin 644 logobig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH
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M5#%YEA\#@9QY:-;GJ5JU"-/><*.'3<:KE']@OC+_ ,%,?AG\&/B9XD^&FL>
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M;&#6K:W\!7^H6T2RRK#?ZQXM@U_4E:0Q@*/MU[>%1)L95*"1(V)1?6_V>_\
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M&&^LTZ<JBP]=4\73:<HMJ4$TYH^"_P!A3]KOX):5^SCX.\%^-OB!X8\%^)/
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M _M:XL+)C\NFQ:G%J-O)<6Z+PDMY:7$T6-L>,L7]KQ4\)_%/A[QFX>\;?#C
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MD>3<08'*X0S[$8#AC*L#&. SW-E-0HY;AL-4PV"PBQ%!8RO2H<W,Z:BU_?\
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M7J]WK?<****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">MOLECULIN BIOTECH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jun. 18,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-37758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-4671997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5300 Memorial Drive, Suite 950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">300-5160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001659617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mbrx20250617_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mbrx.com/20250618/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mbrx-20250618.xsd</File>
    <File>mbrx-20250618_def.xml</File>
    <File>mbrx-20250618_lab.xml</File>
    <File>mbrx-20250618_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mbrx20250617_8k.htm">mbrx20250617_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logobig.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mbrx20250617_8k.htm": {
   "nsprefix": "mbrx",
   "nsuri": "http://www.mbrx.com/20250618",
   "dts": {
    "schema": {
     "local": [
      "mbrx-20250618.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mbrx-20250618_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mbrx-20250618_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbrx-20250618_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mbrx20250617_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 36,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.mbrx.com/20250618/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20250617_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20250617_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Axis]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentDomain",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Domain]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8"
     ]
    },
    "cyd_MaterialCybersecurityIncidentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Table]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mbrx.com/20250618/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-25-020729-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-020729-xbrl.zip
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MV%):IB(KTRD4WL[UJOW4L]#P4;6K)![P=IA01$!T/=,4_,F$/*<$D&.>0,0
MH<:6A6K+ :*=Z43Y,>3QS%;!5-"V-&42^XP08S%+;A(_$Y^LDFMM]W8@WE3Q
M)(&X:6OL[XTF_9249]("<  P9NB]FVIZZY\JB%4!1>XKT@BO3(1;FD8I8-#8
M7+_,.PZD@AOR/%^38L3ZGM1@[?=/KWYX]?9IM>12QVY!1;C]WU<ELCY5!GV=
MK&KA"B@W4=6T,]?%[74]6;N\&))8T5I@;>QBUB_,<K,Q4I#EU0_O/UXV9T /
M*@*W?SPY6135PE>3'\[[KZ[/)V_[DXO;\^MCF,92KNQ83$T!@Z8J8*8ZFQDC
MU/A3C?*'L2!2@6Z_V^?_, [ /"\0*N-^]].& /[X>KL ?'WU5Q[_]L/9.YW=
M/2J 6@[;ZZ1_:PVV6R'=*!7_B^"W\4]MZ\I/82@2DI>5>>P!5@.1")M]Y(I,
M 6<G3M4.N'7YBI$BA&:Z;X@Y8OO,C5<@"D>@3O2!/A%<M$+>SR60@?A2LSOB
M@)&S3>!TGZ]05>?80D:^Q:SCMDFJ28E1B3204+@='ZN 5_$T9KT5B7R,N50F
ML5'VVE[OVKE\U1_N'^V&G*,JJ?@^%1$,78$;7)Q@Z#Z9GIZ4IY<G>^4I56>\
MWGVCKAJST.NZ:@A[]*V3NIL_JF\]2ZKF8"&^^;QJ#2(RE+L3YYXG9HI>@=XV
MD=UJIVH'^7C3$^<EF(F/I]1TJ>,88>U<6C<05UZ450F1<A/O&9&*>_40_7>4
M^ZCN4H 8%#2-O^:CX.QS$MY/6RT] 7>#Z^'@E:=PNQW,S3U)@O?$%03:H]"4
M=A&A*,3[L]O]@\.CH\,7!]^@ZU0EH7F!03#%)IVZ@"+%+:OAQDE7>C3[4.14
M5>=2UVNN^P921)HBER)U5_41*AQ^L43BS8$RH#C6-!<,XA>M8LT,FM;6(FNS
MLH!]24]2O6%2[1_P&'$&/IE#K2NQ<WXYV?4E,&*-U:$?76X=*_ZFP_T[HNUZ
M^7G"+O5((?G?\(R_G!1T3NL1L@+^5LQ]I/(MXWN917R1@B"2*RXR^EP/207W
M;I>_0U:_6?]V)<"N+G\C;[?>VM>KR8GR]UPP[K37KN?PWC,Z^-R_N" 3IUH4
M!4J?SF@3W'Q)%-%!"/YA1J>>%>Y[0J'UGLP]1?C4G'1A[QKB( Q-%17RM$W]
ME)UK4J[J=FM4%!^J@G$3P:EJ%A5ZNKZ)<'B0[CXER(56R*56_.IC_7JZ6Z$>
M=#\U*^'O[=+2W^_[8H?JOC[?W(0JL7-S>[,K$BJ5T8,5"(U56O&86-NHM)9I
M9'-]4.^]43?7=V;KTL3N8,$^$OI$D9ZFB.%NZ_ATF=#6Y=3+LS736(QVQ158
M;9M=4G45B2G9 13&-QV=P$$[LIL7X2&YKNX=OJQBO@GHB6>[7ZB&4I[O;XIM
M=2."&++Z:Y4Y-]GQT7.BX)\\C=Y:]20KF!&YVS@Q$9 R<LWM\,>;0.]#O'D4
MZO\9I?9_-=.F,#I5\S+KT*T=NG3L$%A=,]?K+F6==+DJ$=4V23U?8Z>W'7[=
M8SC]PE6TY]G=+*!1],8]5=3<4_T#0C\(:O [*MTUM56_N>&KO5%(UOR1#G9#
M44QG.>)M7<X!0^NUKPTA\T0K>K03[CAATH2XQ*3A3;'JT]6"BC>*Y4AO%DM)
MEP%<@)6M&YCZSJ\+G5N% .6%W":DFK9R*G;LW,,Q@?RL=%1PFVGXTCQD5:TU
M&[K7K?Z'0U?W@(H4"@0LD1XC /Z&W.Q7/6I;>R7VWQ+:?TMHWU8)C3.K@#N$
M?3]= =L.*,L3;]*TS-0>DLJ,(G[.R'MI8N_:H PY5\8!,CKCYZ=\H]"_N9W<
M/O-W!T2:^8(6%):+Y>V99HS'=%])17W>!S:;TNP>A('U)3\<X7W4%QF]UIN3
M:4$78YYK]P"96<3I9M1:/CQ$Z;!OOYJV[8/+[CL70F@B>E,T.-)P4UJ!B(:C
M40VW#49V@)?P.YP[)  ]?WD)4R1Z!4Y$>P]WTB!,"*1<AOP-0>8_L9#Q>#4H
MZ(GN:^E=3U,.6BZ7@[2^< 4EJ*M!8'P9137,@WY_IO8>_48^K^(W6=T1;1?(
M^Z;&W%';?X2XP<\N_$UN_YVA2\<Y5XGX#MI^J2CPK0CAAOZ50KBVM?7I?8+
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M^L;F[ZUMXL'AT3'I!/C[[W^XJ$#4_Q?T_X^X6"YP7:*AH::A^Q\NJDLA_QO
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MKUOB2!9]\G0JKK"EE\\.+[-'/-7TY%<&QHBN:,I-X '6.+9( :#R_@RLA$6
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MH%OV6RNIQ/;8?V[)S1\H:*Z1N'XH7E<HGL(_:CHX6[N[SJ%TESTYL\E)1&=
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M314R?*_!H7!:!P&L#OIC4HT0 1)C]@J1U?Q[IK+M!1M!O\!72W4P_,U?,;P
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M=ZL+=PU8L-'O-Q@)]*V?\N'3U* 7?_D_3O?'^/\ 4$L#!!0    ( ,H[TEK
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MBS89]N?GW7WUH?Y!*^_\#U!+ P04    " #*.]):CPC?1OD%  !#/   %0
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MB0E?ZU]E6N0E^!71_R1&@K_07?9525(#OP33$<<$A?U#EY53NPILB:4:N)X
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MIH,CR6G]+HR98^9(6EJQ V2F@R-YJ<&NT\F.0W@F"5;\\].Q1/VH?_;BG?\
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M:=T(8+97WH]U!I6E![X!?,B!NJ:C2-ZNDM9IEY0KI0)4W.Z3O_EE\=03'G>
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M.#,Q.34T+FAT;5!+ 0(4 Q0    ( ,H[TEJL^#AU>DD  !1+   +
M      "  2\1  !L;V=O8FEG+FIP9U!+ 0(4 Q0    ( ,H[TEK *P@I@0,
M !D.   1              "  =):  !M8G)X+3(P,C4P-C$X+GAS9%!+ 0(4
M Q0    ( ,H[TEI6ZD(3V00  .4L   5              "  8)>  !M8G)X
M+3(P,C4P-C$X7V1E9BYX;6Q02P$"% ,4    " #*.]):CPC?1OD%  !#/
M%0              @ &.8P  ;6)R>"TR,#(U,#8Q.%]L86(N>&UL4$L! A0#
M%     @ RCO26ILPM4]W!   ?2T  !4              ( !NFD  &UB<G@M
M,C R-3 V,3A?<')E+GAM;%!+ 0(4 Q0    ( ,H[TEK&ZA#:FA(   %S   3
M              "  61N  !M8G)X,C R-3 V,3=?.&LN:'1M4$L%!@     '
-  < O0$  "^!      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>mbrx20250617_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbrx-20250618.xsd" xlink:type="simple"/>
    <context id="d20258K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001659617</identifier>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20258K" id="ixv-257">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20258K" id="ixv-258">0001659617</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20258K" id="ixv-268">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20258K" id="ixv-269">2025-06-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20258K" id="ixv-270">MOLECULIN BIOTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20258K" id="ixv-271">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20258K" id="ixv-272">001-37758</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20258K" id="ixv-273">47-4671997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20258K" id="ixv-274">5300 Memorial Drive, Suite 950</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20258K" id="ixv-275">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20258K" id="ixv-276">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20258K" id="ixv-277">77007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20258K" id="ixv-278">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20258K" id="ixv-279">300-5160</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20258K" id="ixv-280">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20258K" id="ixv-281">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20258K" id="ixv-282">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20258K" id="ixv-283">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20258K" id="ixv-284">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="d20258K" id="ixv-285">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20258K" id="ixv-286">MBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20258K" id="ixv-287">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
